BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Premium Article

Modernizing Your Way to Success in Cell & Gene Therapy Manufacturing

There are now 1,300 companies actively involved in cell and gene therapy manufacturing1 and 11 gene therapy medicinal products with valid marketi...

October 07, 2022 | Opinion | By By James Jardine, GxP Lifeline Editor, MasterControl

Process design and modular facilities to advance sustainability in biomanufacturing

A growing bulk of this demand comes from biologics which have become the mainstay of treatment methods from cancer to autoimmune disorder to viral infectio...

August 15, 2022 | Opinion | By Francis Van Parys, Vice President (Commercial) APAC at Cytiva

Unlocking the Value of Antiviral Drugs for COVID-19 and Beyond

The State of COVID-19 in Asia Pacific Across Asia, over 130 million[1] COVID-19 cases have been reported across 39 countries from the time the first case ...

July 13, 2022 | Opinion | By Dr Paul Shea Tat Ming, Specialist in Geriatrics

" Our partnerships with both NGS & TGS technology giants have facilitated the world’s most comprehensive populations genomics initiative, enabling us to provide cost-effective, high-accuracy sequencing at scale " : Ashish Koshy

What are the major plans in store for G42 Healthcare? Any new segments to be explored? G42 Healthcare is transforming the traditional he...

June 28, 2022 | News

" We are seeing a growing need for contract research organizations (CROs), pharmaceutical companies and regulators in APAC for access to the bioanalysis training needed to conduct drug equivalence tests for the approval of generic drugs " : David Curtin

What are the current opportunities and challenges at Waters ? There is a lot of activity with pharma contract organizations in Asia. F...

June 27, 2022 | Influencers

Transdermal patches: the next frontier in global healthcare

This may come as a surprise, but transdermal and topical technology has been in existence long before injections, and pills became the norm. Ancient histor...

June 10, 2022 | News

"We are thinking about new ways for the HCPs to engage with their patients that will be integrated with existing healthcare IT systems" : Dr Richard Banbury

What could be the impact of new COVID-19 variants on global oncology services? This pandemic has disrupted the spectrum of oncology care and poses...

December 17, 2021 | Opinion

Regulations in Healthcare: Complying in the Cloud

Industry regulations also specify how sensitive data in motion needs to be handled. Common regulations like GDPR, HIPAA and SOC 2 have varying requirement...

November 18, 2021 | Opinion | By Warren Aw, Managing Director APAC at Epsilon

Thermo Fisher Scientific is responding by increasing capacity and diversifying into new geographies and innovative therapies

1) What strategic changes have you brought about within the business due to COVID-19? Essential to Thermo Fisher Scientific’s ability to support bi...

November 12, 2021 | Influencers

Why is the WHO delaying an EUL status to Covaxin?

The World Health Organisation usually takes around 6 to 9 weeks to analyse the data submitted by a vaccine manufacturer and then takes a call on whether to...

October 30, 2021 | Opinion | By "Akhil Pathak , an independent writer who keeps an eye on issues related to health, education, society, global politics and defence. He also follows the geo-strategic matters that are directly or indirectly related to the security framework of India."

How Covid-19 Became a Catalyst for Tracking Health Data and Digitizing Healthcare

Ever since we began living in organized societies, we have attempted to find better ways to manage our health. As a result, we’ve often appointed a f...

October 15, 2021 | Opinion

In Asia, and across the globe, the medical device and diagnostic market was boosted by the pandemic and some quick solutions were developed.

What strategic changes have you brought about within the business due to COVID-19? Bloom Diagnostics decided to make healthcare more acces...

October 11, 2021 | Opinion

We continue to see expansion across each of our key Optimer application areas, therapeutics, bioprocessing, diagnostics, and research reagents

What strategic changes have you brought about within the business due to COVID-19? The COVID-19 pandemic highlighted a number of issues within the l...

October 06, 2021 | Opinion

We expect more first-in-class and biosimilar drugs to be approved and produced in China

Francis Van Parys is currently responsible for providing transformational technologies in biopharmaceutical research, manufacturing and diagnostics to Cyti...

October 04, 2021 | Influencers

Stay Connected